Joseph Wynne

United States Food and Drug Administration

ORCID: 0000-0002-2079-4595

Also affiliated with Center for Drug Evaluation and Research

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia”.

Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2628

N/A

0DataRank · unranked

4 citations

Jörge E. Cortes, Jane F. Apperley, Mel Mann, Michael J. Mauro, Vivian G. Oehler +11 more

Project Confirm: Accelerated Drug Approvals for CML—Response

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3234

N/A

0DataRank · unranked

0 citations

Jörge E. Cortes, Jane F. Apperley, Mel Mann, Michael J. Mauro, Vivian G. Oehler +12 more

FDA Approval Summary: Abatacept for the Prophylaxis of Acute GVHD

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0688

N/A

0DataRank · unranked

3 citations

Donna R. Rivera, Joseph Wynne, Jian Zhao, Robyn Konicki, Aida Kuzucan +8 more